| Disease | dystrophic epidermolysis bullosa |
| Comorbidity | C0007137|squamous cell carcinomas |
| Sentences | 2 |
| PubMedID- 25506404 | Polymeric nanoparticles to combat squamous cell carcinomas in patients with dystrophic epidermolysis bullosa. |
| PubMedID- 20586780 | Background: tumour-specific expression of matrix metalloproteinase (mmp)-7 has been noted in cutaneous squamous cell carcinomas (sccs) in patients with recessive dystrophic epidermolysis bullosa (rdeb). |
Page: 1